CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.06B
1-Year Est. Return 31.81%
This Quarter Est. Return
1 Year Est. Return
+31.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$5.91M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
509
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$8.41M
3
+$6.53M
4
ADI icon
Analog Devices
ADI
+$4.63M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.68M

Top Sells

1
+$7.9M
2
+$7.89M
3
+$6.7M
4
GILD icon
Gilead Sciences
GILD
+$5.26M
5
TSM icon
TSMC
TSM
+$3.61M

Sector Composition

1 Technology 36.93%
2 Healthcare 24.36%
3 Consumer Discretionary 11.82%
4 Communication Services 11.17%
5 Consumer Staples 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV icon
351
KalVista Pharmaceuticals
KALV
$562M
$114K 0.01%
9,912
-417
ANAB icon
352
AnaptysBio
ANAB
$1.01B
$114K 0.01%
6,151
-301
TRVI icon
353
Trevi Therapeutics
TRVI
$1.28B
$113K 0.01%
17,925
+1,627
KURA icon
354
Kura Oncology
KURA
$912M
$107K 0.01%
16,198
-291
MGTX icon
355
MeiraGTx Holdings
MGTX
$745M
$106K 0.01%
15,676
-895
SAGE
356
DELISTED
Sage Therapeutics
SAGE
$98K 0.01%
12,332
-639
SIVR icon
357
abrdn Physical Silver Shares ETF
SIVR
$2.99B
$97.5K 0.01%
3,000
ARVN icon
358
Arvinas
ARVN
$697M
$96.8K 0.01%
13,794
-776
OMER icon
359
Omeros
OMER
$542M
$95.5K 0.01%
11,624
-663
SVRA icon
360
Savara
SVRA
$762M
$95.4K 0.01%
34,424
-1,966
TYRA icon
361
Tyra Biosciences
TYRA
$776M
$94.4K 0.01%
10,150
-580
URGN icon
362
UroGen Pharma
URGN
$934M
$93.6K 0.01%
8,464
-484
HCM icon
363
HUTCHMED
HCM
$2.52B
$93.6K 0.01%
6,221
-356
RLAY icon
364
Relay Therapeutics
RLAY
$1.3B
$89.1K 0.01%
34,003
-1,488
CGEM icon
365
Cullinan Oncology
CGEM
$502M
$88.8K 0.01%
11,737
-609
TBPH icon
366
Theravance Biopharma
TBPH
$710M
$88.1K 0.01%
9,864
-563
PGEN icon
367
Precigen
PGEN
$1.43B
$87.5K 0.01%
58,744
-3,355
PAHC icon
368
Phibro Animal Health
PAHC
$1.69B
$87.1K 0.01%
4,079
-233
MNMD icon
369
MindMed
MNMD
$979M
$86K 0.01%
14,709
-840
PHAT icon
370
Phathom Pharmaceuticals
PHAT
$961M
$86K 0.01%
13,715
-784
MESO
371
Mesoblast
MESO
$2.15B
$85.1K 0.01%
6,822
+46
KROS icon
372
Keros Therapeutics
KROS
$462M
$82.9K 0.01%
8,136
-453
IWY icon
373
iShares Russell Top 200 Growth ETF
IWY
$16.7B
$82.5K 0.01%
391
VERV
374
DELISTED
Verve Therapeutics
VERV
$81.4K 0.01%
17,811
-141
ZVRA icon
375
Zevra Therapeutics
ZVRA
$622M
$80.2K 0.01%
10,706
-612
13 14
15
16 17